![Sunil Agarwal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sunil Agarwal
Direktor/Vorstandsmitglied bei
Nesos, Inc.
Vermögen: 104 816 $ am 31.08.2026
Profil
Sunil Agarwal ist Mitglied des Vorstands von Calithera Biosciences, Inc. und Nesos, Inc. sowie Chief Medical Officer, EVP & Head-Development bei Sana Biotechnology, Inc. In seiner früheren Laufbahn war er Chief Medical Officer & Executive Vice President bei Ultragenyx Pharmaceutical, Inc, Partner bei Sofinnova Investments, Inc, Principal bei Guilford Co, President-Research & Development bei Juno Therapeutics, Inc, Senior VP & Global Head-Clinical Development bei Genentech, Inc, Principal bei MedImmune LLC, Principal bei Kosan Biosciences, Inc. und Assistant Clinical Professor an der GW School of Business. Er erhielt einen Bachelor-Abschluss von der Cornell University und einen Doktortitel von der Tufts University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARVINAS, INC. 0.02% | 31.03.2026 | 11’393 ( 0.02% ) | 104 816 $ | 31.08.2026 |
Aktive Positionen von Sunil Agarwal
| Unternehmen | Position | Beginn |
|---|---|---|
Nesos, Inc.
 Nesos, Inc. Medical SpecialtiesHealth Technology Develops wearable ear buds and software solutions for noninvasive pain therapy | Direktor/Vorstandsmitglied | - |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Direktor/Vorstandsmitglied | 18.04.2023 |
Norwest Venture Partners
 Norwest Venture Partners Investment ManagersFinance Norwest Venture Partners invests in companies located in North America, India and Israel. The firm focuses on companies operating across a broad range of sectors and industries.It participates in early and later stage transactions with an investment size of USD 10 - 100 million. | Private Equity Investor | 01.10.2024 |
Ehemalige bekannte Positionen von Sunil Agarwal
| Unternehmen | Position | Ende |
|---|---|---|
| ARVINAS, INC. | Direktor/Vorstandsmitglied | 24.06.2026 |
| ASTRIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 23.01.2026 |
| SANA BIOTECHNOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 10.04.2023 |
| CALITHERA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 01.01.2023 |
| MYOKARDIA, INC. | Direktor/Vorstandsmitglied | 17.11.2020 |
Ausbildung von Sunil Agarwal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
19
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 19 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for allergic & immunologic diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Norwest Venture Partners
Norwest Venture Partners Investment ManagersFinance Norwest Venture Partners invests in companies located in North America, India and Israel. The firm focuses on companies operating across a broad range of sectors and industries.It participates in early and later stage transactions with an investment size of USD 10 - 100 million. | Finance |
Guilford Co.
 Guilford Co. Finance/Rental/LeasingFinance Guilford Co. specializes in providing textile solutions, including fabrics and materials for industries such as automotive, aerospace, and furniture, with a focus on durability and performance. The private company is based in VA. | Finance |
Calithera Biosciences, Inc.
 Calithera Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics to control cancer and other diseases | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The GW School of Business
 The GW School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Nesos, Inc.
Nesos, Inc. Medical SpecialtiesHealth Technology Develops wearable ear buds and software solutions for noninvasive pain therapy | Health Technology |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Health Technology |
Curie Bio Operations LLC
 Curie Bio Operations LLC Investment ManagersFinance Curie Bio invests in companies located in the United States. The firm targets companies operating in the fields of the biotech. It provides financing for seed stage capital requirements. | Finance |
